Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
2.340
0.00 (0.00%)
Nov 26, 2025, 4:00 PM EST - Market closed
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $96.14 million as of November 28, 2025. Its market cap has increased by 119.36% in one year.
Market Cap
96.14M
Enterprise Value
85.78M
1-Year Change
119.36%
Ranking
Category
Stock Price
$2.34
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $96.14M, a decrease of -40.97%. That is a compound annual growth rate of -10.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 96.14M | 120.66% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
| May 7, 2021 | 162.86M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |